Azam Ghafoor

Trials

Studies that name Azam Ghafoor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:27 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04027946 · LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  National Cancer Institute (NCI) · terminated · Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma of Lung · principal investigator
• Ph2
  NCT02759835 · Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib

  National Cancer Institute (NCI) · completed · Lung Adenocarcinoma, Lung Neoplasms · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 17:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.